DRUG
Bright Minds Biosciences Inc. Common Stock
$28.380+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$28.380
High
$28.380
Low
$28.380
Volume
0.01M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. ("Bright Minds," "BMB" or the "Company") (NASDAQ:DRUG), a pioneering company focused on developing highly
View more
Analyst Upgrades
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside
Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite limited clinical data.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.